2023-11-23 03:36:40
Cameroon received, on the night of Tuesday November 21 to Wednesday November 22, 2023, its first delivery of Mosquirix anti-malaria vaccines manufactured by the British from the Gavi alliance. Cameroon is the first African country to receive the vaccine following the pilot phase which took place in Ghana, Kenya and Malawi.
Published on: 11/23/2023 – 04:36
1 mn
With our correspondent in Yaoundé, Richard Onanena
Cameroon received 331,200 doses of Mosquirix also known as RTS-S, the first anti-malaria vaccine recommended by the WHO.
According to Doctor Shalom Tchokfe, permanent secretary of the country’s expanded immunization program, this vaccine is of great help in the fight once morest malaria: “ With its capacity to reduce deaths by at least a third, we can hope to go further to achieve a new level of results. »
This first batch of vaccine should cover 42 health districts, insufficient for a country which has 203. It therefore complements the good old methods of malaria prevention, recalls the Minister of Health, Malachie Manaouda. “ The vaccine will not kill mosquitoes. We need to take the precautions we took before. This is just an additional measure to help us prevent fairly high mortality rates. »
According to the WHO, malaria causes nearly 11,000 deaths each year in Cameroon. Around 400,000 children aged 6 to 24 months should benefit from the first doses of this vaccine in a four-dose schedule.
Read alsoWHO gives the green light to a second malaria vaccine for children
1700711324
#Arrival #Mosquirix #malaria #vaccines #Cameroon
